WAVE Life Sciences Ltd (WVE) showcases significant progress in RNA technologies and a strong financial position, despite ...

Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by their role in targeting DNA repair vulnerabilities.

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Worldwide Healthcare Trust PLC - Half-year Financial Report PR Newswire LONDON, United Kingdom, November 13 LONDON STOCK EXCHANGE ANNOUNCEMENT Worldwide ...

DataJoint, a leading informatics platform revolutionizing data management and analysis in scientific research and the life sciences sector, today announced the appointment of John Apathy as a ...